News Digging > Popular > Pfizer buys Seagen, maker of targeted cancer drugs, for $43 billion
Pfizer buys Seagen, maker of targeted cancer drugs, for  billion
Pfizer buys Seagen, maker of targeted cancer drugs, for $43 billion,Pfizer said it is acquiring Seagen, a maker of targeted cancer drugs, for $43 billion.

Pfizer buys Seagen, maker of targeted cancer drugs, for $43 billion

The Seagan deal helps Pfizer, in need of new sources of revenue, by adding a lineup of cancer drugs called antibody-drug conjugates.